Recipient-Based Approach to Tailoring Immunosuppression in Liver Transplantation

Abstract Improvements in the field of transplant immunosuppression (IS) have led to significant advances in long-term survival of liver transplant recipients. Despite this progress, survival rates vary depending on recipient, donor and/or perioperative factors. Tailoring IS based on recipient factor...

Full description

Saved in:
Bibliographic Details
Published inTransplantation proceedings Vol. 42; no. 5; pp. 1731 - 1737
Main Authors Kemmer, N, Neff, G
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.06.2010
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Improvements in the field of transplant immunosuppression (IS) have led to significant advances in long-term survival of liver transplant recipients. Despite this progress, survival rates vary depending on recipient, donor and/or perioperative factors. Tailoring IS based on recipient factors is of growing interest among health care providers involved in the care of organ transplant recipients. To date there is no consensus document addressing individualized IS therapy for liver transplant recipients. This review will discuss the information available on the effect of the various IS drugs on recipient-based factors such as age, ethnicity, and liver disease etiology.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0041-1345
1873-2623
DOI:10.1016/j.transproceed.2010.02.076